HEART SCREEN UK LTD

Name

HEART SCREEN UK LTD

Legal name

Heart Screen UK Limited

Website

https://heartscreen.co.uk

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Cardiac Diagnostics & Preventive Heart Screening Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

akta.pro secondary industries

Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE), Cardiac Diagnostic Centers (Echo/Stress Testing/Holter) (HLAFAKAE), ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• Heart screening services
• Cardiac diagnostics distribution
• Cardiovascular health screening
• Workplace health screening
• Pharmacy health screening

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Cardisio Heart Screening Tests: Revenue generated from facilitating Cardisio heart screening tests through pharmacies, workplaces, and direct consumer channels. Tests are priced and sold as individual procedures with instant results.
2. Data Analysis Services: Online service where data captured from patients using Cardisiograph devices is transmitted to Cardisio GmbH's facility in Germany for analysis. Heart Screen UK facilitates this service as part of the product offering.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Heart Screen UK Ltd is the Premier UK Distributor of Cardisio GmbH's Cardisiography (CSG) heart screening technology. The company delivers non-invasive, AI-powered 4-minute 3D vectorcardiography tests through community pharmacies, workplace health programs, and direct-to-consumer booking, enabling early detection of coronary heart disease, arrhythmias, and structural heart defects before symptoms develop.

Product overview

Heart Screen UK Ltd operates as the Premier UK Distributor of Cardisio GmbH's cardiac screening products and services. The core offering is the Cardisiograph (Cardisio Heart Test) device, a non-invasive AI-powered diagnostic tool that uses 3D vectorcardiography to detect heart disease early. Data captured by the device is transmitted to Cardisio Cloud for AI analysis, generating PDF reports with risk scores. The company offers this technology through two main channels: community pharmacy services for individual consumers and workplace health programs for corporate clients. Cardisiography (CSG) is the underlying technology platform that captures over 95% of the heart's electrical activity compared to traditional ECGs, processed through proprietary AI algorithms continuously trained with confirmed clinical findings.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardisio Heart Test (Cardisiograph)

Quantifiable outcome

• Sensitivity: 97% (males), 90% (females) for detecting coronary heart disease
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

One partnership is on record.

• Cardisio GmbHcoreChannel Partner/ Reseller/ DistributorHeart Screen UK Ltd is the Premier UK Distributor of Cardisio products and Cardisiography technology. Cardisio GmbH, founded in 2016 and headquartered in Frankfurt am Main, manufactures the Cardisiograph devices and provides the Data Analysis Service. Heart Screen UK brings Cardisio products to the UK Market with expertise in Sales and Marketing, Clinical Studies, and Information Technology.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Preventicum: UK private clinic delivering executive health checks that include cardiac screening (ECG, echocardiography and imaging). Directly comparable to Heart Screen UK's workplace and consumer cardiovascular screening proposition, particularly for self-pay and employer-sponsored health-assessment buyers.
• AliveCor: AliveCor's KardiaMobile is a consumer/clinical single-lead ECG device offering AI-interpreted heart rhythm reports in under a minute. It competes head-on with Heart Screen UK's pharmacy-channel proposition of fast, non-invasive, AI-interpreted cardiac screening for asymptomatic and at-risk consumers.

Emerging players

• Huma (formerly Medopad): Huma builds remote patient monitoring and digital health platforms used across NHS pathways, including cardiovascular disease management. Comparable to Heart Screen UK at the layer of digital cardiovascular risk assessment deployed within UK primary/secondary care settings.
• HeartFlow: HeartFlow offers AI-enabled, non-invasive cardiac diagnostic analysis (FFR-CT) for coronary artery disease. Comparable as a non-invasive, AI-augmented cardiac diagnostic addressing the same underlying CVD detection problem that Heart Screen UK targets, although HeartFlow's modality is CT-derived rather than ECG-based.
• Eko Health: Eko Health combines digital stethoscopes and ECG sensors with AI-based cardiac analysis (FDA-cleared algorithms for arrhythmia and murmur detection). Comparable to Heart Screen UK's model of pairing a connected sensing device with cloud-based AI interpretation for frontline screening.

Broad incumbents

• Philips Healthcare (Cardiac Monitoring): Philips is a major manufacturer of clinical 12-lead ECG and cardiac monitoring systems sold globally and used in UK NHS hospitals. It represents the established incumbent standard ECG infrastructure against which Heart Screen UK's 3D vectorcardiography positions as a superior non-invasive alternative.
• Bupa Health Assessments: Bupa operates a large UK private-pay health assessment network which includes cardiovascular checks for individuals and corporate clients. It is an incumbent alternative channel that competes with Heart Screen UK's workplace and consumer cardiac screening offerings.
• iRhythm Technologies: iRhythm's Zio wearable cardiac monitor combines ECG capture with cloud-based AI analysis to detect arrhythmias. Comparable to Heart Screen UK in offering AI-augmented cardiac diagnostics delivered outside hospital settings, though focused on longer-duration rhythm monitoring rather than 4-minute risk screening.
• Cardisio GmbH: The German manufacturer of the Cardisiograph technology and operator of the Cardisio Cloud analysis service. As the upstream technology owner and the parent/strategic partner of Heart Screen UK, it is the most direct comparability reference for the underlying product and analysis economics that Heart Screen UK distributes.

Others

• GE HealthCare (ECG / Cardiology): GE HealthCare supplies hospital-grade ECG machines, cardiology information systems and resting ECG carts widely used in UK clinics. While not a direct distribution competitor, it anchors the incumbent installed base of standard ECG technology that Heart Screen UK must displace or augment to win clinical referrals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/heartscreenuk

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HEART SCREEN UK LTD